Association of molecular subtypes in bladder cancer with response to neoadjuvant chemotherapy, progression and survival
Considering the molecular subtype of muscle-invasive bladder cancer (MIBC) based on differences in tumor RNA expression can improve the ability of an existing tumor biomarker, such as the COXEN score, to predict which patients' ...
Nov 15, 2023
0
0